tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Seres Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsSeres Therapeutics Reports Q2 2025 Financial Results
2M ago
Seres Therapeutics Reports Q2 Results and Leadership Change
Premium
Company Announcements
Seres Therapeutics Reports Q2 Results and Leadership Change
2M ago
Seres Therapeutics reports Q2 EPS ($2.27) vs ($4.34) last year
Premium
The Fly
Seres Therapeutics reports Q2 EPS ($2.27) vs ($4.34) last year
2M ago
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
PremiumRatingsBuy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
5M ago
Seres Therapeutics downgraded to Neutral from Buy at Chardan
Premium
The Fly
Seres Therapeutics downgraded to Neutral from Buy at Chardan
5M ago
Seres Therapeutics Reports Positive Q1 2025 Results
Premium
Company Announcements
Seres Therapeutics Reports Positive Q1 2025 Results
5M ago
Seres Therapeutics presents three posters at DDW Conference
PremiumThe FlySeres Therapeutics presents three posters at DDW Conference
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
Seres Therapeutics trading resumes
Premium
The Fly
Seres Therapeutics trading resumes
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100